How I Play the Biotechs Real Money Pro($)

A strategy to immunize biotech investors from regret.
Its Alzheimer's treatment impressed, but dosing questions remain.
Looking at technicals going against parabolic moves.
The stock recently generated a long-term overbought signal.
Where are Celgene, Isis and CVS heading?
Here are healthcare stocks of all shares and sizes with strong charts.
Own them, or take something off the table?
A small biotech gem with lots of potential.
I really like the stocks. But I also like making money on stocks.

HCA Is Still Worth Holding Real Money Pro($)

Growing health care company has more room to run.

Columnist Conversations

With the suspension of IPOs by the Chinese authorities, will the "go private" offers wither and die? I think...
The morning is going to be dominated by the ramifications by the No vote in Greece over the weekend. I would ...
If the pattern of the last six years holds, you do revisit the low on the futures so even if you love the pric...
Simple case of "simple minds think alike?"


News Breaks

Powered by

Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.